UDs and Implants Safe and Effective for Teens, ACOG Says .


Long-acting contraceptives — namely, intrauterine devices and the contraceptive implant — “are the best reversible methods for preventing unintended pregnancy, rapid repeat pregnancy, and abortion in young women,” according to a committee opinion from the American College of Obstetricians and Gynecologists.

Published in Obstetrics & Gynecology, the statement outlines evidence supporting both the safety and efficacy of long-acting contraceptive methods in adolescent girls. In particular, research shows that teenagers using long-acting methods are far more likely to continue using those methods at 1 year — and 20 times less likely to have an unintended pregnancy — compared with those using short-acting methods. In addition, complication rates with long-acting contraception do not differ between women and teenage girls.

Just 4.5% of adolescent girls who use contraceptives use an IUD or implant, according to one estimate.

The authors write that long-acting methods “should be first-line treatment recommendations for all women and adolescents,” and “counseling about [such] methods should occur at all health care provider visits with sexually active adolescents.”

Source:Obstetrics & Gynecology

 

Meta-Analysis: Progestin-Only Pills, IUDs Don’t Increase VTE Events.


Progestin-only pills and intrauterine devices do not increase the risk for venous thromboembolic events, according to a meta-analysis in BMJ. However, an association between injectable progestin and VTE could not be ruled out.

The meta-analysis included three retrospective cohort studies and five case-control studies comparing progestin-only contraception use with no hormone use. Overall, progestin-only methods were not associated with VTE risk — a finding that held true in subanalyses of progestin-only pills and IUDs. Use of injectable progestin was associated with a doubling of risk, although only two studies evaluated this formulation.

The authors call for more research into the potential increase in risk with injectable progestin. “In the interim,” they conclude, “we suggest consideration of non-injectable forms of progestin-only contraception for highest risk women.”

Source: BMJ